Their headquarters stand less than two kilometres apart, on opposite sides of the river Rhine in the city of Basel in Switzerland.
But the strategies adopted by pharmaceutical groups Roche and Novartis could not be more different. They exemplify the growing divergence in the sector, one that has been intensified by the financial crisis.
